Patent · US Expired

Bioavailable oral dosage form of cefuroxime axetil

US6323193A · kind A · utility

13Cited by
5References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 21, 2000
Grant dateNov 27, 2001
Priority date
Expiry dateAug 21, 2020

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2095
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a bioavailable oral dosage form comprising of amorphous cefuroxime axetil containing from 7 to 25% crystalline cefuroxime axetil.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.